Jump to content
PC Security Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

Mason Joe

  • entries
    13
  • comments
    0
  • views
    63

Entries in this blog

‘Patient Recruitment and Retention Services, 2019-2030’ <Roots Analysis>

To order this detailed 300+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html   Key Inclusions §  A detailed assessment of the current market landscape, including information on drug developer(s), §  A detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including information on over 10 types of patient outre

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment <Roots Analysis>

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are actively offering patient recruitment and retention services. Majority of these players possess vast service portfolios and utilize diverse patient outreach methods to recruit study participants across different geographie

Patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, <till 2030>

Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Marker, 2019-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 300+ page report, which features 90+ figures and 140+ tables, please visit this -https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html   Key Market Insights §  Presently, close to

Patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, <Roots Analysis>

A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers   Roots Analysis  is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker, 2019-2030.”   The report offers a comprehensive study of the current scenario and future potential of the

“Endocannabinoid System Targeted Therapeutics Market, 2020-2030”

To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html   Key Inclusions §  A detailed assessment of the current market landscape of endocannabinoid system targeted therapeutics, providing information on phase of development (clinical, preclinical, and discovery stage) of lead candidates, target therapeutic area (s), route of administration (oral, topi

Presently engaged in evaluating the clinical applications of over 180 cannabinoid-derivatives

Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids.   To order this 250+ page report, which features 140+ figures

The endocannabinoid system is projected to grow at an annualized rate of ~30%, (till 2030)

Roots Analysis has done a detailed study on Endocannabinoid System Targeted Therapeutics Market, 2020-2030 “ covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html   Key Market Insights §  More than 65 industry players across the world a

The endocannabinoid system targeted therapeutics market < Roots Analysis>

So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions   Roots Analysis is pleased to announce the publication of its recent study, titled, Endocannabinoid System Targeted Therapeutics Market, 2020-2030   The report features an extensive study of the current market landscape, offering an informe

Endocannabinoid system targeted therapeutics market is growing at an annualized rate of 30%, (Roots Analysis)

So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions   London   Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings.   Over time, extensive R&D on the potential health benefits of can

“Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030”

To order this detailed 350+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html   Key Inclusions §  A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory),  type of therapeutic moda

The potential of nearly 300 next generation immune checkpoint modulators for the treatment (Roots Analysis)

Over time, significant strides have been made in immune checkpoint research, resulting in the discovery of several inhibitory (LAG-3, TIM-3, TIGIT, VISTA and B7-H3) and stimulatory receptors (OX40, ICOS, GITR, 4-1BB and CD40), which are being investigated as potential targets for therapy development. Further, studies of combinatorial immune checkpoint blockade / co-stimulation, targeting newly identified checkpoints along with known checkpoint inhibitor therapies, have demonstrated promising cli

Inhibitors and stimulators market is projected to grow at an annualized rate of ~15% (till 2030)

Roots Analysis has done a detailed study on Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030., covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 350+ page report, which features 140+ figures and 170+ tables, please visit this link   Key Market Insights §  More than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next g

The next generation immune checkpoint inhibitors and stimulators market (Roots Analysis)

Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions   Roots Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030.”   The report features an extensive study of the current market landscape,
×
  • Create New...